PAP-2d Inhibitors
PAP-2d inhibitors are a class of chemical compounds that specifically target and inhibit the activity of phosphatidic acid phosphatase type 2d (PAP-2d), an enzyme involved in lipid metabolism and signal transduction. PAP-2d, also known as lipid phosphate phosphatase 3 (LPP3), plays a critical role in the dephosphorylation of lipid phosphate intermediates such as phosphatidic acid (PA), lysophosphatidic acid (LPA), and other bioactive lipids. This enzymatic activity regulates the balance between lipid signaling molecules and their corresponding dephosphorylated forms, which are important for controlling various cellular processes, including membrane dynamics, cell proliferation, and motility. By inhibiting PAP-2d, these compounds interfere with lipid signaling pathways, providing a way to investigate the biological roles of PAP-2d in cellular lipid metabolism and its broader influence on cell behavior.
The mechanism of action for PAP-2d inhibitors typically involves the selective binding to the enzyme's active site, preventing it from catalyzing the conversion of phosphatidic acid and other substrates into their dephosphorylated products. This inhibition disrupts the normal lipid signaling cascades, allowing researchers to explore the downstream effects on cellular functions such as cytoskeletal organization, membrane trafficking, and lipid storage. PAP-2d inhibitors are particularly valuable in studying how lipid signaling molecules like LPA regulate processes such as inflammation, migration, and differentiation. Through the targeted modulation of PAP-2d activity, these inhibitors help uncover the enzyme's specific roles in maintaining the delicate balance of lipid mediators, which are essential for cellular homeostasis and intercellular communication. These insights contribute to a deeper understanding of how lipid metabolism interfaces with cell signaling and regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol inhibits the activation of protein kinase C (PKC), which is necessary for the activity of Phosphatidic acid phosphatase type 2d as PKC can phosphorylate and activate it. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 alters the phosphorylation state of multiple proteins, which can indirectly lead to the inhibition of Phosphatidic acid phosphatase type 2d. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K), and by inhibiting PI3K, it can inhibit Phosphatidic acid phosphatase type 2d activity as PI3K can generate phosphatidylinositol (3,4,5)-trisphosphate (PIP3) which is a substrate for lipid phosphatases. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits mitogen-activated protein kinase kinase (MEK), which impairs the extracellular signal-regulated kinase (ERK) pathway that can regulate lipid signaling pathways involving Phosphatidic acid phosphatase type 2d. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mammalian target of rapamycin (mTOR), which is part of the PI3K-related kinase family; mTOR inhibition can decrease the phosphorylation of proteins downstream in lipid signaling pathways that include Phosphatidic acid phosphatase type 2d. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is an inhibitor of PI3K, and by inhibiting PI3K, it can reduce the production of PIP3, which in turn can inhibit the activity of Phosphatidic acid phosphatase type 2d due to altered lipid signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 selectively inhibits p38 MAP kinase, which is involved in signaling pathways that can regulate lipid metabolism and potentially inhibit Phosphatidic acid phosphatase type 2d indirectly by affecting these pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 selectively inhibits MEK, which in turn can inhibit ERK activation. This disruption can inhibit signaling pathways involving Phosphatidic acid phosphatase type 2d. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinase (JNK), which can regulate various cellular processes, including those that influence the function of lipid phosphatases like Phosphatidic acid phosphatase type 2d. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP 2 is an inhibitor of Src family kinases, which are involved in multiple signaling pathways that can regulate the activity of lipid phosphatases including Phosphatidic acid phosphatase type 2d. | ||||||